NCT02683577View on ClinicalTrials.gov

Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Hepatic Impairment

Interventions

DRUG

telotristat etiprate

Trial Locations (2)

MD-2025

ARENSIA Exploratory Medicine, Chisinau

050159 Distr

ARENSIA Exploratory Medicine, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Ipsen

INDUSTRY

NCT02683577 - Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy Subjects | Biotech Hunter | Biotech Hunter